ACGT Summit 2026 Marks 25 Years of Progress in Cancer Cell and Gene Therapy
Summary
The ACGT Summit 2026 marked the 25th anniversary of the Alliance for Cancer Gene Therapy, celebrating the evolution of cell and gene therapy from experimental concept to proven treatment. With nine approved products and over 60,000 patients treated globally, the field has answered whether these therapies work. The invitation-only summit gathered nearly 100 leading experts at the Alexandria Center for Life Science in New York City to address the next challenge: making these therapies accessible and effective for all patients everywhere.
Source
bskyACGT Summit 2026 Marks 25 Years of Progress in Cancer Cell and Gene Therapyacgtfoundation.orgKey quotes
· 3 pulledWhen Alliance for Cancer Gene Therapy (ACGT) was founded 25 years ago, the question hanging over cancer cell and gene therapy was a stark one: Could it work at all?
With nine approved products and over 60,000 patients treated worldwide, the answer is a resounding yes.
ACGT gathered nearly 100 of the field's leading minds for ACGT Summit 2026... to answer a very different question—not whether these therapies work, but how to make them work everywhere and for everyone.
You might also wanna read
KDT 2026 Conference: Second Meeting on Ketogenic Dietary Therapies Announced in Salzburg
The article announces the second Conference on Ketogenic Dietary Therapies (KDT) 2026, taking place from November 12-14, 2026 at Paracelsus
keto-med.com·1d agoKDT 2026 Conference: Second Meeting on Ketogenic Dietary Therapies Announced in Salzburg
The article announces the second Conference on Ketogenic Dietary Therapies (KDT) 2026, taking place from November 12-14, 2026 at Paracelsus
keto-med.com·1d ago
International Collaboration Advances Synthetic Cell Research
The article discusses the emerging field of synthetic cell (SynCell) research, which aims to build artificial cells from molecular component
nature.com·8mo agoAsk HN: What is the latest on treatment of Metastatic Breast Cancer?
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
rockefeller.edu·9mo ago
Examining the Reality Behind Claims That ChatGPT Cured a Dog's Cancer
The article examines a viral story about an Australian tech entrepreneur who claimed ChatGPT helped cure his dog's cancer. While the narrati
The Verge·3mo ago
Synergistic senolytic–regenerative therapy significantly extends healthspan and lifespan
Comments
Sign in to join the conversation.
No comments yet. Be the first.